文献速递心脑血管急症消化、代谢与肾脏急症重症综合管理与镇静镇痛

创伤性脑损伤与慢性心血管、内分泌、神经及精神疾病风险的关联

Association of Traumatic Brain Injury With the Risk of Developing Chronic Cardiovascular, Endocrine, Neurological, and Psychiatric Disorders.
PubMed 文献 · JAMA Netw Open · 2022-04-01
一句话结论无基线共病的TBI患者(含mTBI)10年内高血压、糖尿病、卒中/TIA及精神疾病风险显著升高,且共病出现中位3.49年后与死亡风险增高相关,作者建议伤后靶向筛查多系统疾病。

这项前瞻性纵向队列研究利用某三级学术医疗中心医院患者登记数据,纳入2000至2015年无任何临床共病的TBI患者,并按年龄、性别、种族频数匹配无头部外伤且无目标共病的未暴露个体,随访至多10年。mTBI、msTBI及未暴露组各4351例,中位年龄分别45、47、46岁,每组女性均占45%。mTBI和msTBI均与心血管、内分泌、神经及精神疾病风险升高相关,其中高血压mTBI HR 2.5(95%CI 2.1-2.9)、msTBI HR 2.4(95%CI 2.0-2.9);所有共病在伤后中位3.49年(IQR 1.76-5.96)出现。msTBI较未暴露组死亡风险更高(432例死亡[9.9%] vs 250例死亡[5.7%],P<.001),伤后高血压、冠心病及肾上腺功能不全与死亡风险升高相关。作者认为需要针对TBI后多系统疾病尤其是慢性心脏代谢疾病开展靶向筛查。

要点

  • mTBI与msTBI患者高血压风险均约为未暴露组的2倍以上:mTBI HR 2.5(95%CI 2.1-2.9),msTBI HR 2.4(95%CI 2.0-2.9)。
  • 糖尿病风险mTBI HR 1.9(95%CI 1.4-2.7)、msTBI HR 1.9(95%CI 1.4-2.6);缺血性卒中或TIA风险mTBI HR 2.2(95%CI 1.4-3.3)、msTBI HR 3.6(95%CI 2.4-5.3)。
  • 所有TBI后共病出现的中位时间为伤后3.49年(IQR 1.76-5.96),提示随访窗口应覆盖伤后数年。
  • 18至40岁人群中,mTBI组高血压HR 5.9(95%CI 3.9-9.1)、msTBI组HR 3.9(95%CI 2.5-6.1);mTBI组高脂血症HR 2.3(95%CI 1.5-3.4)、糖尿病HR 4.6(95%CI 2.1-9.9)。
  • msTBI组死亡432例(9.9%) vs 未暴露组250例(5.7%),P<.001;伤后高血压HR 1.3(95%CI 1.1-1.7)、冠心病HR 2.2(95%CI 1.6-3.0)、肾上腺功能不全HR 6.2(95%CI 2.8-13.0)与死亡风险升高相关。

适用人群与场景

  • 2000至2015年某三级学术医疗中心医院登记数据中,无任何既往临床共病、发生mTBI或msTBI的患者。
  • 对照为同一登记中无头部外伤且无目标共病的个体,按年龄、性别、种族频数匹配至TBI亚组。
  • 随访至多10年,数据分析于2021年进行。

诊断标准与关键阈值

  • 心血管、内分泌、神经及精神疾病依据国际疾病分类第九版(ICD-9)或疾病和有关健康问题的国际统计分类第十版(ICD-10)定义。
  • TBI严重程度分为mTBI与msTBI。

研究设计与关键结果

  • 研究类型:前瞻性纵向队列研究,基于某三级学术医疗中心医院患者登记数据;mTBI组4351例(中位年龄45岁,IQR 29-57),msTBI组4351例(中位年龄47岁,IQR 30-58),未暴露组4351例(中位年龄46岁,IQR 30-58);每组女性均占45%。
  • mTBI和msTBI均与心血管、内分泌、神经及精神疾病风险升高相关;高血压mTBI HR 2.5(95%CI 2.1-2.9)、msTBI HR 2.4(95%CI 2.0-2.9);糖尿病mTBI HR 1.9(95%CI 1.4-2.7)、msTBI HR 1.9(95%CI 1.4-2.6);缺血性卒中或TIA mTBI HR 2.2(95%CI 1.4-3.3)、msTBI HR 3.6(95%CI 2.4-5.3)。
  • 所有TBI亚组共病均在伤后中位3.49年(IQR 1.76-5.96)出现。
  • 18至40岁人群中,与年龄匹配未暴露个体相比,高血压mTBI HR 5.9(95%CI 3.9-9.1)、msTBI HR 3.9(95%CI 2.5-6.1);mTBI组高脂血症HR 2.3(95%CI 1.5-3.4)、糖尿病HR 4.6(95%CI 2.1-9.9)。
  • msTBI组较未暴露组死亡风险更高:432例死亡(9.9%) vs 250例死亡(5.7%),P<.001;伤后高血压HR 1.3(95%CI 1.1-1.7)、冠心病HR 2.2(95%CI 1.6-3.0)、肾上腺功能不全HR 6.2(95%CI 2.8-13.0)与死亡风险升高相关。

证据类型、等级与局限

  • 证据类型:前瞻性纵向队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,TBI后需针对多系统疾病开展靶向筛查,尤其是慢性心脏代谢疾病。
  • 作者指出,共病可见于相对年轻的TBI患者,且TBI后出现的共病与死亡风险升高相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Increased risk of neurological and psychiatric conditions after traumatic brain injury (TBI) is well-defined. However, cardiovascular and endocrine comorbidity risk after TBI in individuals without these comorbidities and associations with post-TBI mortality have received little attention.

OBJECTIVE: To assess the incidence of cardiovascular, endocrine, neurological, and psychiatric comorbidities in patients with mild TBI (mTBI) or moderate to severe TBI (msTBI) and analyze associations between post-TBI comorbidities and mortality.

DESIGN, SETTING, AND PARTICIPANTS: This prospective longitudinal cohort study used hospital-based patient registry data from a tertiary academic medical center to select patients without any prior clinical comorbidities who experienced TBI from 2000 to 2015. Using the same data registry, individuals without head injuries, the unexposed group, and without target comorbidities were selected and age-, sex-, and race-frequency-matched to TBI subgroups. Patients were followed-up for up to 10 years. Data were analyzed in 2021.

EXPOSURES: Mild or moderate to severe head trauma.

MAIN OUTCOMES AND MEASURES: Cardiovascular, endocrine, neurologic, and psychiatric conditions were defined based on International Classification of Diseases, Ninth Revision (ICD-9) or International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). Associations between TBI and comorbidities, as well as associations between the comorbidities and mortality, were analyzed.

RESULTS: A total of 4351 patients with mTBI (median [IQR] age, 45 [29-57] years), 4351 patients with msTBI (median [IQR] age, 47 [30-58] years), and 4351 unexposed individuals (median [IQR] age, 46 [30-58] years) were included in analyses. In each group, 45% of participants were women. mTBI and msTBI were significantly associated with higher risks of cardiovascular, endocrine, neurologic, and psychiatric disorders compared with unexposed individuals. In particular, hypertension risk was increased in both mTBI (HR, 2.5; 95% CI, 2.1-2.9) and msTBI (HR, 2.4; 95% CI, 2.0-2.9) groups. Diabetes risk was increased in both mTBI (HR, 1.9; 95% CI, 1.4-2.7) and msTBI (HR, 1.9; 95% CI, 1.4-2.6) groups, and risk of ischemic stroke or transient ischemic attack was also increased in mTBI (HR, 2.2; 95% CI, 1.4-3.3) and msTBI (HR, 3.6; 95% CI, 2.4-5.3) groups. All comorbidities in the TBI subgroups emerged within a median (IQR) of 3.49 (1.76-5.96) years after injury. Risks for post-TBI comorbidities were also higher in patients aged 18 to 40 years compared with age-matched unexposed individuals: hypertension risk was increased in the mTBI (HR, 5.9; 95% CI, 3.9-9.1) and msTBI (HR, 3.9; 95% CI, 2.5-6.1) groups, while hyperlipidemia (HR, 2.3; 95% CI, 1.5-3.4) and diabetes (HR, 4.6; 95% CI, 2.1-9.9) were increased in the mTBI group. Individuals with msTBI, compared with unexposed patients, had higher risk of mortality (432 deaths [9.9%] vs 250 deaths [5.7%]; P < .001); postinjury hypertension (HR, 1.3; 95% CI, 1.1-1.7), coronary artery disease (HR, 2.2; 95% CI, 1.6-3.0), and adrenal insufficiency (HR, 6.2; 95% CI, 2.8-13.0) were also associated with higher mortality.

CONCLUSIONS AND RELEVANCE: These findings suggest that TBI of any severity was associated with a higher risk of chronic cardiovascular, endocrine, and neurological comorbidities in patients without baseline diagnoses. Medical comorbidities were observed in relatively young patients with TBI. Comorbidities occurring after TBI were associated with higher mortality. These findings suggest the need for a targeted screening program for multisystem diseases after TBI, particularly chronic cardiometabolic diseases.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Izzy S, Chen PM, Tahir Z, et al. Association of Traumatic Brain Injury With the Risk of Developing Chronic Cardiovascular, Endocrine, Neurological, and Psychiatric Disorders. JAMA Netw Open. 2022. PMID: 35482306. doi:10.1001/jamanetworkopen.2022.9478

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。